The AI in oncology market is projected to experience significant growth, with an expected value of USD 54.71 billion by 2035, expanding at a compound annual growth rate (CAGR) of 26.23% from 2026 to 2035. This surge is primarily attributed to the increasing global cancer incidence, the rise in precision medicine adoption, and the integration of AI technologies in cancer diagnostics and treatment planning.
Currently, over 20 million new cancer cases are diagnosed each year, prompting healthcare providers to leverage AI solutions for enhanced early detection and treatment options. AI systems are demonstrating remarkable accuracy, with some achieving over 90% in diagnostic predictions, thereby facilitating faster clinical decisions. The demand for precision oncology is further fueling this market, as AI tools are capable of integrating various data types—including genomic, imaging, and clinical information—to optimize treatment strategies.
The segmentation of the market reveals that hardware currently dominates, holding a 40.2% share due to the demand for advanced computing infrastructure. However, software solutions are anticipated to grow rapidly as they become increasingly integrated with diagnostic platforms. Breast cancer remains the largest segment within the market, attributed to advancements in imaging technologies, while prostate cancer is expected to see the fastest growth due to AI-assisted imaging innovations.
Regionally, North America is leading the market, driven by high healthcare digitization rates and early adoption of AI in precision medicine. The U.S. market alone is projected to grow from USD 1.38 billion in 2025 to USD 8.26 billion by 2035. In contrast, Europe and the Asia-Pacific region are also experiencing substantial growth, with Europe benefiting from robust healthcare systems and Asia-Pacific capitalizing on government support for AI initiatives.
This rapid expansion of the AI in oncology market signifies not only technological advancements but also a crucial shift towards personalized cancer care, potentially transforming treatment outcomes and patient experiences in the years to come.